HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Vietnam
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    • #Personal Health
  • Newletter
  • Events
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS
    • Home
    • #Global Trends
    • #Vietnam
    • #M&A
    • #Regulations
    • #Knowledge
      • #Corporate Wellness
      • #Human Resources
      • #Capability Development
      • #Personal Health
    • Newletter
    • Events

    Tag: #M&A

    BMS and Hengrui Pharma Form Multi-Billion Strategic Alliance for 13 Early-Stage Programs

    14/05/2026 Published by vivi

    Bristol Myers Squibb (BMS) and Hengrui Pharma have entered into a major global strategic collaboration to advance a portfolio of... Read more

    Category: Uncategorized
    Tags: #M&A

    OrganaBio Acquires Excellos Assets to Establish Coast-to-Coast Cell Therapy CDMO

    14/05/2026 Published by vivi

    OrganaBio has announced the substantial acquisition of all operating assets from San Diego-based Excellos. This move officially establishes a bicoastal... Read more

    Category: Uncategorized
    Tags: #M&A

    Leading Vietnamese pharmaceutical firms transition to foreign control

    13/05/2026 Published by vivi

    The Vietnamese pharmaceutical landscape is experiencing a significant influx of international capital, with nearly all top-tier firms by market capitalization... Read more

    Category: Uncategorized
    Tags: #M&A

    Livzon Group completes acquisition, securing majority control of Imexpharm Pharmaceutical

    12/05/2026 Published by vivi

    The Vietnamese pharmaceutical landscape has seen a significant shift in corporate ownership at Imexpharm Pharmaceutical JSC (Ticker: IMP). As of... Read more

    Category: Uncategorized
    Tags: #M&A

    Angelini Pharma acquires Catalyst for $4.1B to fulfill U.S. growth ambitions

    08/05/2026 Published by ViNe

    Angelini Pharma, a historic Italian family-owned company, has announced a $4.1 billion agreement to acquire Florida-based Catalyst Pharmaceuticals. This marks... Read more

    Category: Uncategorized
    Tags: #M&A

    Roche to acquire PathAI for over $1 billion to transform AI-driven diagnostics

    07/05/2026 Published by ViNe

    Roche has announced a definitive merger agreement to acquire PathAI, a leader in digital pathology and AI-powered technology. This acquisition... Read more

    Category: Uncategorized
    Tags: #M&A

    Bayer to acquire Perfuse for up to $2.45B to bolster its ophthalmology pipeline

    07/05/2026 Published by ViNe

    Bayer has agreed to acquire San Francisco-based biotech startup Perfuse Therapeutics in a deal potentially worth $2.45 billion. This marks... Read more

    Category: Uncategorized
    Tags: #M&A

    Merck completes $5.8 billion acquisition of Terns Pharmaceuticals

    06/05/2026 Published by ViNe

    Merck (known as MSD outside the U.S. and Canada) has announced the successful completion of its acquisition of Terns Pharmaceuticals.... Read more

    Category: Uncategorized
    Tags: #M&A

    Teva inks $900M Emalex buyout to expand Tourette syndrome pipeline

    06/05/2026 Published by ViNe

    Teva Pharmaceuticals has proposed the acquisition of Emalex Biosciences, a move that integrates a promising pediatric Tourette syndrome therapy into... Read more

    Category: Uncategorized
    Tags: #M&A

    Posts pagination

    Previous page Page 1 … Page 8 Page 9 Page 10 … Page 16 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved